Immuno-oncology Clinical Trials Market Growth Information Analysis Report 2028
Immuno-oncology Clinical Trials Industry Overview The global immuno-oncology clinical trials market size is expected to reach USD 15.1 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 13.6% from 2021 to 2028. The rapidly growing field of Immuno-oncology has emerged as a novel therapeutic area within the oncology ecosystem, transforming the treatment of cancer. Immuno-oncology Clinical Trials Market Segmentation Grand View Research has segmented the global immuno-oncology clinical trials market based on phase, design, indication, and region: Based on the Phase Insights, the market is segmented into Phase I, Phase II, Phase III, and Phase IV. The phase III segment dominated the market with 53.1% of revenue share in 2020. This is largely attributed that Phase III is roughly USD 59,500. Oncology trials also have a lower average number of trials are the most expensive ones and involve huge subjects. ...